All In MedTech

Device Trial Radar · NCT04674969

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

5,000

Planned (sponsor's estimate)

Start

Mar 29, 2021

Primary completion

Jan 2028

Study completion Jan 2028

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Dec 19, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.

Conditions

  • Peripheral Vascular Diseases

Interventions

  • Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.Device

    Ranger™ Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter; ELUVIA™ Drug-Eluting Vascular Stent System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major Adverse EventsTime frame: 12 months
  2. Lesion PatencyTime frame: 12 months

Locations

89 sites in 13 countries. Site status is shown where the registry gives one.

  • St. Bernard's Medical Center

    Jonesboro, Arkansas · Recruiting

  • PIH Health Good Samaritan Hospital

    Los Angeles, California · Recruiting

  • Cedars - Sinai Medical Center

    Los Angeles, California · Recruiting

86 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.